{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:56:50Z","timestamp":1764403010258,"version":"3.41.2"},"reference-count":12,"publisher":"Ubiquity Press, Ltd.","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,6]]},"DOI":"10.5334\/tohm.431","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T13:31:22Z","timestamp":1601991082000},"source":"Crossref","is-referenced-by-count":4,"title":["Ziconotide-Induced Oro-lingual Dyskinesia: 3 Cases"],"prefix":"10.5334","volume":"10","author":[{"given":"Kristopher","family":"Grajny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Durphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavian","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmeen","family":"Azher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Molho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3285","reference":[{"year":"2004","author":"Elan Corporation","key":"key20201006093116_B1"},{"issue":"5","key":"key20201006093116_B2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.9740\/mhc.2018.09.242","article-title":"Ziconotide-induced psychosis: A case report and literature review","volume":"8","year":"2018","journal-title":"Mental Health Clinician"},{"issue":"1","key":"key20201006093116_B3","first-page":"97","article-title":"Ziconotide-induced psychosis: A case report","volume":"37","year":"2015","journal-title":"General hospital psychiatry"},{"issue":"2","key":"key20201006093116_B4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3928\/00485713-20150212-02","article-title":"Ziconotide-associated psychosis treated with Invega","volume":"45","year":"2015","journal-title":"Psychiatric Ann"},{"issue":"3","key":"key20201006093116_B5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/pme.12005","article-title":"Prolonged delirium with psychotic features from omega conotoxin toxicity","volume":"14","year":"2013","journal-title":"Pain Med"},{"issue":"1","key":"key20201006093116_B6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1176\/appi.psy.43.1.63","article-title":"Intractable delirium associated with ziconotide successfully treated with electroconvulsive therapy","volume":"43","year":"2002","journal-title":"Psychosomatics"},{"issue":"2","key":"key20201006093116_B7","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1213\/ane.0b013e3181606fad","article-title":"Ziconotide 98-022 Study Group. Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial","volume":"106","year":"2008","journal-title":"Anesthesia & Analgesia"},{"issue":"1","key":"key20201006093116_B8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1525-1403.2006.00044.x","article-title":"A prospective, open-label study of long-term intrathecal ziconotide for chronic nonmalignant back pain: A case report","volume":"9","year":"2006","journal-title":"Neuromodulation: Technology at the Neural Interface"},{"key":"key20201006093116_B9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/AAP.0000000000000054","article-title":"Dyskinesia caused by ziconotide-baclofen combination in an adolescent affected by cerebral palsy","volume":"39","year":"2014","journal-title":"Reg Anesth Pain Med"},{"issue":"5","key":"key20201006093116_B10","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1152\/jn.00516.2010","article-title":"Upregulation of D2-class signaling in dopamine-denervated striatum is in part mediated by D3 receptors acting on CaV2.1 channels via PIP2 depletion","volume":"105","year":"2011","journal-title":"J Neurophysiol"},{"issue":"11","key":"key20201006093116_B11","first-page":"21159","article-title":"Oral and genital tardive pain syndromes","volume":"44","year":"1994","journal-title":"Neurology"},{"first-page":"493","volume-title":"Principles and Practice of Movement Disorders","year":"2007","key":"key20201006093116_B12"}],"container-title":["Tremor and Other Hyperkinetic Movements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/doi.org\/10.5334\/tohm.431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T09:24:15Z","timestamp":1657531455000},"score":1,"resource":{"primary":{"URL":"https:\/\/tremorjournal.org\/articles\/10.5334\/tohm.431\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,10,6]]}},"alternative-id":["10.5334\/tohm.431"],"URL":"https:\/\/doi.org\/10.5334\/tohm.431","relation":{},"ISSN":["2160-8288"],"issn-type":[{"type":"electronic","value":"2160-8288"}],"subject":[],"published":{"date-parts":[[2020]]},"article-number":"37"}}